Search research articles
Contact Us
Filters
Showing results (141-150 of 372) with videos related to
Page
of 38
Sort By:
Expert Opinion on Biological Therapy
|
December 23, 2011
Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management
Mauro Viganò, Elisabetta Degasperi, Alessio Aghemo, et al.
Journal of Hepatology
|
September 25, 2009
HCV genotype 3: an independent predictor of fibrosis progression in chronic hepatitis C
Stella De Nicola, Alessio Aghemo, Maria Grazia Rumi, et al.
Thrombosis Research
|
October 20, 2006
Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinoma
Eugenia Biguzzi, Franca Franchi, Paolo Bucciarelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 12, 2020
A letter of solidarity during the COVID-19 pandemic
Jeffrey V Lazarus, Francesco Negro, Manal El-Sayed, et al.
Hepatology (Baltimore, Md.)
|
September 3, 2010
Twelve-week posttreatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapy
Alessio Aghemo, Maria Grazia Rumi, Stella De Nicola, et al.
Hepatology (Baltimore, Md.)
|
January 30, 2009
The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?
Alessio Aghemo, Maria Grazia Rumi, Gian Maria Prati, et al.
Seminars in Liver Disease
|
February 29, 2020
Postsustained Virological Response Management in Hepatitis C Patients
Chiara Masetti, Ana Lleo, Matteo Colombo, et al.
Expert Review of Anti-Infective Therapy
|
May 1, 2013
PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history
Elisabetta Degasperi, Mauro Viganò, Alessio Aghemo, et al.
Therapeutic Advances in Medical Oncology
|
July 20, 2019
The risk of liver cancer in autoimmune liver diseases
Ana Lleo, Ynto S de Boer, Rodrigo Liberal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 19, 2016
Sofosbuvir-based regimens for the treatment of hepatitis C virus in patients who underwent lung transplant: case series and review of the literature
Roberta D'Ambrosio, Alessio Aghemo, Valeria Rossetti, et al.
Page
of 38
Search research articles
Search
Showing results (141-150 of 372) with videos related to
Sort By:
Page
of 38
Expert Opinion on Biological Therapy
|
December 23, 2011
Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management
Mauro Viganò, Elisabetta Degasperi, Alessio Aghemo, et al.
Journal of Hepatology
|
September 25, 2009
HCV genotype 3: an independent predictor of fibrosis progression in chronic hepatitis C
Stella De Nicola, Alessio Aghemo, Maria Grazia Rumi, et al.
Thrombosis Research
|
October 20, 2006
Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinoma
Eugenia Biguzzi, Franca Franchi, Paolo Bucciarelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 12, 2020
A letter of solidarity during the COVID-19 pandemic
Jeffrey V Lazarus, Francesco Negro, Manal El-Sayed, et al.
Hepatology (Baltimore, Md.)
|
September 3, 2010
Twelve-week posttreatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapy
Alessio Aghemo, Maria Grazia Rumi, Stella De Nicola, et al.
Hepatology (Baltimore, Md.)
|
January 30, 2009
The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?
Alessio Aghemo, Maria Grazia Rumi, Gian Maria Prati, et al.
Seminars in Liver Disease
|
February 29, 2020
Postsustained Virological Response Management in Hepatitis C Patients
Chiara Masetti, Ana Lleo, Matteo Colombo, et al.
Expert Review of Anti-Infective Therapy
|
May 1, 2013
PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history
Elisabetta Degasperi, Mauro Viganò, Alessio Aghemo, et al.
Therapeutic Advances in Medical Oncology
|
July 20, 2019
The risk of liver cancer in autoimmune liver diseases
Ana Lleo, Ynto S de Boer, Rodrigo Liberal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 19, 2016
Sofosbuvir-based regimens for the treatment of hepatitis C virus in patients who underwent lung transplant: case series and review of the literature
Roberta D'Ambrosio, Alessio Aghemo, Valeria Rossetti, et al.
Page
of 38